Cancer treatment–induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients
Supportive Care in Cancer · 2025
DOI: 10.1007/s00520-024-09071-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Minu Ponnamma Mohan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Boston Medical Center, Boston University School of Medicine, Boston, MA, 02118, USA. Hauptthemen laut MEDLINE: Deglutition Disorders, Cost of Illness, Length of Stay, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Themen: Onkologische Pflege, Dysphagie
Abstract (Originalsprache)
BACKGROUND: Our study aims to assess the association between chemotherapy-induced oral ulcerative mucositis (CT-UM) or radiotherapy-induced oral ulcerative mucositis (RT-UM) and the burden of illness (BOI), dysphagia, and disparities among patients with cancers of the oral cavity, lip, and pharynx (CLOP) and hematopoietic stem cell transplant patients (HSCT). METHODS: The study used US national data to investigate the association between UM and the BOI-length of stay (LOS) and dysphagia. The BOI was measured by length of stay (LOS), dysphagia, and associated disparities in these outcomes. This investigation was conducted using generalized linear models (glm). RESULTS: An analysis was conducted on a sample of 820 patients with CT-UM and 1010 patients with RT-UM, out of a total of 59,710 hospitalized CLOP patients, and 1380 patients with CT-UM from 10,885 total hospitalized HSCT patients. Among, CLOP patients, CT-UM status was associated with increased LOS (Coeff,1.54; 95% CI 1.36 to 1.74) and also associated with a greater likelihood of dysphagia (aOR, 2.11; 95% CI 1.52-2.95). However, among CLOP, RT-UM status was also associated with increased LOS (Coeff, 1.33; 95% CI 1.14-1.55), but there was no association of d RT-UM status and dysphagia (aOR = 1.21; 95% CI 0.84-1.77). Among HSCT patients, CT-UM status was associated with increased LOS and greater likelihood of dysphagia (Coeff, 1.09; 95% CI 1.02-1.16 and aOR = 2.08; 95% CI 1.11-3.9, respectively). Further, UM outcomes disproportionately affect females, Blacks, Hispanics, Medicaid recipients, and those with lower incomes. CONCLUSION: The findings highlight the need for more effective methods of screening for and preventing UM in order to decrease BOI, especially in the context of systemic treatments. Additionally, new computational methods including artificial intelligence for mucositis prediction should be the center of future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Boston Medical Center, Boston University School of Medicine, Boston, MA, 02118, USA.
- Department of Medicine, Division of Hematology and Oncology, University at Buffalo, Buffalo, NY, 14203, USA.
- City of Hope Comprehensive Cancer Center, Duarte CA and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical System, Los Angeles, CA, USA.
- Department of Medicine, University at Buffalo, Buffalo, NY, 14203, USA.
- Department of Medicine, Division of Hematology and Oncology, University at Buffalo, Buffalo, NY, 14203, USA. spoolakk@buffalo.edu.
Zitieren
APA
Mohan, M. P., Pili, R., Epstein, J. B., Rudin, L., Eichhorn, S., & Satheeshkumar, P. S. (2025). Cancer treatment–induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-09071-4
Vancouver
Mohan MP, Pili R, Epstein JB, Rudin L, Eichhorn S, Satheeshkumar PS. Cancer treatment–induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients. Supportive Care in Cancer. 2025. doi:10.1007/s00520-024-09071-4
BibTeX
@article{Mohan2025,
author = {Mohan, Minu Ponnamma and Pili, Roberto and Epstein, Joel B and Rudin, Lauryn and Eichhorn, Susan and Satheeshkumar, Poolakkad S},
title = {Cancer treatment–induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients},
journal = {Supportive Care in Cancer},
year = {2025},
doi = {10.1007/s00520-024-09071-4}
}
EUVIMED